EUVIMEDDescoperă EUVIMED
Open access

Selective kidney targeting increases the efficacy of mesenchymal stromal/stem cells for alleviation of murine stenotic‐kidney senescence and damage

Seo Rin Kim iD, Kai Jiang, Xiaojun Chen, Amrutesh S Puranik, Xiang-Yang Zhu, Amir Lerman, Tamara Tchkonia, James L Kirkland, Lilach O Lerman iD

Journal of Tissue Engineering and Regenerative Medicine · 2022-06 · 16 (6) · 550-558

DOI: 10.1002/term.3299 ↗

At a glance

Journal article in Journal of Tissue Engineering and Regenerative Medicine, published online on 2022-03-23. Written by Seo Rin Kim and 8 co-authors. Institution: Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA. Major MEDLINE topics: Mesenchymal Stem Cells, Renal Artery Obstruction. Cited 15 times so far (Crossref); 30 references. The full text is freely available in PubMed Central. Funded by: NIDDK NIH HHS, NIA NIH HHS, National Institutes of Health.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Chronic ischemia triggers senescence in renal tubules and at least partly mediates kidney dysfunction and damage through a p16Ink4a -related mechanism. We previously showed that mesenchymal stromal/stem cells (MSCs) delivered systemically do not effectively decrease cellular senescence in stenotic murine kidneys. We hypothesized that selective MSC targeting to injured kidneys using an anti-KIM1 antibody (KIM-MSC) coating would enhance their ability to abrogate cellular senescence in murine renal artery stenosis (RAS). KIM-MSC were injected into transgenic INK-ATTAC mice, which are amenable for selective eradication of p16Ink4a+ cells, 4 weeks after induction of unilateral RAS. To determine whether KIM-MSC abolish p16Ink4a -dependent cellular senescence, selective clearance of p16Ink4a+ cells was induced in a subgroup of RAS mice using AP20187 over 3 weeks prior to KIM-MSC injection. Two weeks after KIM-MSC aortic injection, renal senescence, function, and tissue damage were assessed. KIM-MSC delivery decreased gene expression of senescence and senescence-associated secretory phenotype factors, and improved micro-MRI-derived stenotic-kidney glomerular filtration rate and perfusion. Renal fibrosis and tubular injury also improved after KIM-MSC treatment. Yet, their efficacy was slightly augmented by prior elimination of p16Ink4a+ senescent cells. Therefore, selective targeting of MSC to the injured kidney markedly improves their senolytic potency in murine RAS, despite incomplete eradication of p16+ cells. KIM-MSC may constitute a useful therapeutic strategy in chronic renal ischemic injury.

Subjects

MeSH terms (MEDLINE)

Mesenchymal Stem CellsRenal Artery ObstructionAnimalsCellular SenescenceCyclin-Dependent Kinase Inhibitor p16IschemiaKidneyMiceMice, Transgenic

Author keywords

cellular senescencekidney injury molecule-1mesenchymal stem cellsrenal artery stenosis

Substances

Cyclin-Dependent Kinase Inhibitor p16

Authors and institutions

  • Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Internal Medicine and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University School of Medicine and Pusan National University Yangsan Hospital, Yangsan, Korea.
  • Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Department of Cardiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota, USA.

ORCID profiles: Seo Rin Kim, Lilach O Lerman

Funding

  • NIDDK NIH HHS
  • NIA NIH HHS
  • National Institutes of Health

Cite

APA

Kim, S. R., Jiang, K., Chen, X., Puranik, A. S., Zhu, X. Y., Lerman, A., Tchkonia, T., Kirkland, J. L., & Lerman, L. O. (2022). Selective kidney targeting increases the efficacy of mesenchymal stromal/stem cells for alleviation of murine stenotic‐kidney senescence and damage. Journal of Tissue Engineering and Regenerative Medicine, 16(6), 550-558. https://doi.org/10.1002/term.3299

Vancouver

Kim SR, Jiang K, Chen X, Puranik AS, Zhu XY, Lerman A, et al. Selective kidney targeting increases the efficacy of mesenchymal stromal/stem cells for alleviation of murine stenotic‐kidney senescence and damage. Journal of Tissue Engineering and Regenerative Medicine. 2022;16(6):550-558. doi:10.1002/term.3299

BibTeX
@article{Kim2022,
  author = {Kim, Seo Rin and Jiang, Kai and Chen, Xiaojun and Puranik, Amrutesh S and Zhu, Xiang-Yang and Lerman, Amir and Tchkonia, Tamara and Kirkland, James L and Lerman, Lilach O},
  title = {Selective kidney targeting increases the efficacy of mesenchymal stromal/stem cells for alleviation of murine stenotic‐kidney senescence and damage},
  journal = {Journal of Tissue Engineering and Regenerative Medicine},
  year = {2022},
  volume = {16},
  number = {6},
  pages = {550--558},
  doi = {10.1002/term.3299}
}
Start for free →